Medical Economics January 10, 2024
Josh Disbrow

It’s time for pharmaceutical companies and others to innovate and disrupt the distribution side of treatment.

America leads the world in developing prescription drugs. But we’re far less savvy at ensuring patients can easily afford and access them.

Our process of getting patients the medication they need is opaque and confusing. Almost a quarter of Americans with insurance have reported that a prescription was unavailable through their plan or required a very high copay. Nearly one in five were surprised to discover that their plans wouldn’t pay for care they thought was covered.

Americans deserve better, starting with greater transparency. It’s time for pharmaceutical companies and others to innovate and disrupt the distribution side of treatment, not just the medical...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Healthcare System, Pharma, Pharma / Biotech, Pricing / Spending
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
Bariatric Surgeons Being Put Out of Work by GLP-1 Drugs
The CMS NHE 2023 Report: An Incomplete Picture at a Pivotal Time
Mark Cuban's 2025 plans
Pharma At A Crossroads: Navigating Cost Pressures And Regulatory Shifts In 2025

Share This Article